Figure 2.
Percent change from baseline of pharmacodynamic markers of fibroblast growth factor receptor (FGFR) pathway inhibition. A, Serum phosphate. B, Fibroblast growth factor 23 (FGF23). C, 1,25‐(OH)2‐vitamin D (cycle 1 day 15)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.